Imperial College Healthcare NHS Trust
London, W12 0NN, United Kingdom
Location status: Recruiting
Location contact
Ahran Arnold
CONTACT
Keenan Saleh, MBBS
CONTACT
Zachary Whinnett, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06988189
This study seeks to evaluate whether using non-invasive electrocardiograph (ECG) techniques, including long term ECG monitoring with wearable ECGs, can improve the detection of concealed Brugada syndrome.
Interested in participating?
Request Info18 year–100 year
All sexes
Observational
London, W12 0NN, United Kingdom
Location status: Recruiting
Ahran Arnold
CONTACT
Keenan Saleh, MBBS
CONTACT
Zachary Whinnett, PhD
PRINCIPAL_INVESTIGATOR
Application of long term continuous ECG monitoring via ECG wearables and ambulatory ECG monitors to detect manifestations of Brugada syndrome. This approach will be combined with development of an AI (artificial intelligence) enabled ECG platform to automate Brugada ECG detection and analysis.
The protocol will comprise the following parts:
Study A: Brugada ECG AI development. This will automate the recognition of the type 1 Brugada ECG pattern on 12 lead ECGs.
Study B: Remote arrhythmia diagnostics. A prospective observational study whereby recruited participants will be fitted with a wearable ECG or cardiac monitor to undergo continuous long term ambulatory ECG monitoring. The algorithms developed in study A will be applied to long term ECG data captured in this study.
Study C: Arrhythmic risk stratification using ultra-high-frequency ECG. This exploratory study will look for markers of arrhythmic risk in patients with manifest and concealed arrhythmia syndromes.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
12-lead ECG from a conventional ECG machine
Continuous long term ambulatory ECG monitoring using wearable ECG or cardiac monitor
Ultra-high-frequency ECG acquired using specific acquisition equipment
Time frame: At completion of algorithm validation, approximately 12 months after study start
Assessment of performance and accuracy of AI ECG detection algorithm for type 1 Brugada ECG.
Time frame: Up to 12 months from enrolment
AI ECG detection algorithm, developed in Study A, applied to full ECG recording to detect Type 1 Brugada ECG pattern.
Time frame: Up to 12 months from enrolment
AI ECG detection algorithms applied to full ECG recording to detect Type 1 Brugada ECG pattern or LQTS unmasking.
Contact information is provided by the study sponsor or research team.
Ahran Arnold, PhD
CONTACT
Keenan Saleh, MBBS
CONTACT
Imperial College London
Other
Acronym: UCAS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06647927
Arrhythmias, Cardiac, Brugada Syndrome
San Donato Milanese, Milan, Italy
View Trial DetailsNCT07655102
Anesthesia, Arrhythmias, Cardiac
Barcelona, Spain
View Trial DetailsNCT07364656
Arrhythmias, Cardiac, Autoantibodies Screening
Milan, Italy
View Trial DetailsNCT02413450
Aortic Stenosis, Subvalvular, Aortic Valve Disease
Baltimore, Maryland, United States
View Trial Details